Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
Melanotan-1, referred to in much of the literature as afamelanotide (and historically as NDP-MSH), is a synthetic linear analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied primarily as an agonist at the melanocortin 1 receptor (MC1R), the receptor subtype expressed on epidermal melanocytes that governs the cellular switch toward eumelanin synthesis. Within melanocortin research, this peptide serves as a stable probe for investigating how sustained MC1R activation influences pigment biology and the responses associated with ultraviolet (UV) exposure.
Interest in this molecule centers on photoprotection and on erythropoietic protoporphyria (EPP), a rare inherited metabolic condition frequently used as a model system in phototoxicity research. The sections below summarize what Melanotan-1 is, how its target pathway is described in preclinical and mechanistic studies, and why it appears so often in the photoprotection literature. Every statement here is offered for research use only, not for human consumption, and describes what the molecule is investigated for rather than any application in people.
Molecular Identity and Classification
Melanotan-1 is derived from native alpha-MSH by two defining substitutions: replacement of the methionine at position 4 with norleucine (Nle), and substitution of the L-phenylalanine at position 7 with its D-enantiomer (D-Phe). These modifications, introduced during early melanotropin research, increase resistance to enzymatic degradation and prolong activity at melanocortin receptors while preserving the full 13-residue linear backbone of the parent hormone. The result is a comparatively long-acting analog that remains structurally close to the endogenous ligand.
Identity Reference
The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Attribute | Reported Value |
|---|---|
| Common designations | Melanotan-1, afamelanotide, NDP-MSH, [Nle4, D-Phe7]-alpha-MSH |
| Parent molecule | alpha-melanocyte-stimulating hormone (alpha-MSH) |
| Amino acid length | 13 residues (linear) |
| Key substitutions | Norleucine at position 4, D-phenylalanine at position 7 |
| Molecular formula | C78H111N21O19 |
| Approximate molecular weight | 1646.9 g/mol |
| Peptide class | Synthetic melanocortin receptor agonist |
| Primary studied target | Melanocortin 1 receptor (MC1R) |
MC1R Signaling and Photoprotection Mechanisms
The rationale for studying Melanotan-1 in photoprotection research rests on the biology of the melanocortin 1 receptor. MC1R is a G-protein-coupled receptor on melanocytes, and its activation is the principal upstream event that biases pigment synthesis toward the darker, UV-absorbing eumelanin fraction. Because Melanotan-1 is a potent and metabolically stabilized MC1R agonist, it is used to model what happens when this pathway is driven persistently.
The Eumelanin Switch
Agonist binding at MC1R stimulates adenylate cyclase and raises intracellular cyclic AMP (cAMP). Elevated cAMP promotes activity of microphthalmia-associated transcription factor (MITF) and downstream pigmentation enzymes such as tyrosinase, shifting melanocyte output from the lighter pheomelanin toward eumelanin. In cell and animal models, this cascade is the central mechanism through which sustained melanocortin signaling increases eumelanin content.
Studied Photoprotective Correlates
Eumelanin is of interest in UV research because it absorbs and scatters ultraviolet radiation and can interact with reactive species generated during light exposure. In preclinical systems, increased eumelanin has been associated with lower levels of UV-linked oxidative markers and reduced formation of certain DNA-damage products. Investigators therefore use MC1R agonists such as Melanotan-1 to probe how the pigmentary response relates to cellular resilience under UV challenge, keeping the work firmly within mechanistic, research-model territory.
Erythropoietic Protoporphyria as a Research Model
Erythropoietic protoporphyria (EPP) is a genetic disorder of heme biosynthesis in which reduced activity of the enzyme ferrochelatase leads to accumulation of protoporphyrin IX. When protoporphyrin IX is exposed to visible and ultraviolet light, it becomes photoactivated and generates reactive oxygen species, producing pronounced phototoxic reactions in affected tissue. This well-characterized biochemistry makes EPP a valuable model system for studying light-triggered cellular stress.
Within this research context, Melanotan-1 is examined because MC1R-driven eumelanin induction represents a plausible route to attenuating light-associated damage without altering the underlying enzyme defect. Studies in this area investigate whether increasing eumelanin density changes the amount of light reaching photoactive porphyrins and how downstream oxidative signaling responds. The EPP literature is thus a major reason the compound appears so frequently in photoprotection research, and it illustrates how a pigmentation pathway is used as an experimental lever rather than as a described human application.
Comparative Context and Laboratory Handling
Melanotan-1 is best understood alongside its structural relatives. Placed next to native alpha-MSH and the cyclic analog Melanotan-2, the linear 13-mer occupies a distinct position: it stays close to the endogenous sequence while gaining stability, and it is generally described as more MC1R-preferential than the broader-acting cyclic peptide.
The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Attribute | Melanotan-1 (Afamelanotide) | alpha-MSH (native) | Melanotan-2 |
|---|---|---|---|
| Structure | Linear 13-mer | Linear 13-mer | Cyclic 7-mer lactam |
| Approx. molecular weight | 1646.9 g/mol | 1664.9 g/mol | 1024.2 g/mol |
| Receptor profile studied | MC1R-preferential | Broad melanocortin | MC1R, MC3R, MC4R |
| Backbone stability | Enhanced vs native | Native (rapidly degraded) | Enhanced (cyclized) |
| Common research focus | Photoprotection and pigment biology | Endogenous signaling reference | Broad melanocortin pigment studies |
Laboratory Handling Notes
Research-grade Melanotan-1 is typically distributed as a lyophilized powder and reconstituted with bacteriostatic water for in-vitro work; the bacteriostatic water reconstitution guide covers the general procedure. As a worked example, reconstituting a 10 mg vial with 2 mL of bacteriostatic water yields a 5 mg/mL stock solution. Because the peptide is light-sensitive and vulnerable to repeated freeze-thaw cycling, aliquots are generally stored cold and shielded from light. Identity and purity should be confirmed against a batch certificate of analysis, with published certificates providing an additional record of consistency. Related melanocortin research materials are listed in the broader research peptide catalog.
Frequently Asked Questions
What is Melanotan-1 (afamelanotide)?
Melanotan-1 is a synthetic 13-amino-acid analog of alpha-MSH, also known as afamelanotide or NDP-MSH. In melanocortin research it is used as a stable agonist at the melanocortin 1 receptor (MC1R) to study eumelanin synthesis and pigment biology. It is handled strictly as a laboratory research material.
How is afamelanotide connected to photoprotection research?
Afamelanotide activates MC1R on melanocytes, which in preclinical models shifts pigment production toward eumelanin. Because eumelanin absorbs and scatters ultraviolet light and is linked to reduced oxidative markers, the peptide is widely used as a probe in photoprotection and UV-response research.
What is the difference between Melanotan-1 and Melanotan-2?
Melanotan-1 is a linear 13-residue peptide that is comparatively MC1R-preferential, while Melanotan-2 is a smaller cyclic 7-residue analog that engages multiple melanocortin receptors including MC1R, MC3R, and MC4R. The two are studied for overlapping pigment-related questions but differ in structure, molecular weight, and receptor breadth.
Why is erythropoietic protoporphyria used in this research?
Erythropoietic protoporphyria (EPP) is a genetic condition in which ferrochelatase deficiency causes protoporphyrin IX to accumulate, producing strong phototoxic reactions on light exposure. It serves as a model system for studying whether MC1R-driven eumelanin induction can mitigate light-triggered cellular stress.
What is the molecular weight and sequence length of Melanotan-1?
Melanotan-1 has an approximate molecular weight of 1646.9 g/mol and a molecular formula of C78H111N21O19. It retains the 13-residue linear backbone of alpha-MSH, with norleucine substituted at position 4 and D-phenylalanine at position 7.
Is Melanotan-1 intended for human use?
No. Materials described here are supplied for research use only, not for human consumption, self-administration, or any therapeutic application. This article summarizes laboratory and mechanistic research only and does not describe use in people.
References and Further Reading
- Hruby VJ, Hadley ME, and colleagues (University of Arizona): development of the linear alpha-MSH analog [Nle4, D-Phe7]-alpha-MSH. PubMed: Nle4 D-Phe7 alpha-MSH melanotropin
- Melanocortin 1 receptor (MC1R) signaling and eumelanin synthesis in melanocytes. PubMed: MC1R eumelanin melanogenesis
- Afamelanotide and photoprotection research. PubMed: afamelanotide photoprotection
- Langendonk JG, et al. (2015): afamelanotide studied in the context of erythropoietic protoporphyria. PubMed: afamelanotide erythropoietic protoporphyria
- Ferrochelatase deficiency and protoporphyrin IX accumulation in erythropoietic protoporphyria. PubMed: erythropoietic protoporphyria ferrochelatase
- alpha-Melanocyte-stimulating hormone and the cutaneous melanocortin system. PubMed: alpha-MSH melanocortin system skin
- Melanocortin pathway and ultraviolet (UV) photoprotection research. PubMed: melanocortin UV photoprotection
